Reply to: Optimising vancomycin doses in continuous infusion for septic patients

International Journal of Antimicrobial Agents

Volumn 37, Issue 4, 2011, Pages 385-386

  Jeurissen, A ^a   Sluyts, I ^a   Rutsaert, R ^a  

^a Sint Vincentiusziekenhuis   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; VANCOMYCIN;

AREA UNDER THE CURVE; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MEGADOSE; DRUG OVERDOSE; HUMAN; LETTER; LOADING DRUG DOSE; NEPHROTOXICITY; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SEPSIS; STEADY STATE; URINARY EXCRETION;

EID: 79952816982     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.12.008     Document Type: Letter

References (5)

1. Jeurissen A, Sluyts I, Rutsaert R. A higher dose of vancomycin in continuous infusion is needed in critically ill patients. Int J Antimicrob Agents 2011;37:75-7.
2. Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 2008;52:1330-6. (Pubitemid 351521995)
3. Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA,Billeter M, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009;49:325-7.
4. Pea F, Furlanut M, Negri C, Pavan F, Crapis M, Cristini F, et al. Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients. Antimicrob Agents Chemother 2009;53:1863-7.
5. Kees GK, Hilpert JW, Gnewuch C, Kees F, Voegeler S. Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C. Int J Antimicrob Agents 2010;36:545-8.